Publications by authors named "Mayer Fishman"

Claim this Profile
A
Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic.
Jonathan Chatzkel, Mayer Fishman, Brian Ramnaraign, Padraic O'Malley, Guru P Sonpavde

Res Rep Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer.
Jonathan Chatzkel, Michael J Schell, Jad Chahoud, Jingsong Zhang, Rohit Jain, Mayer Fishman

Clin Genitourin Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, Sumanta K Pal, Ulka Vaishampayan, Mayer N Fishman

Clin Genitourin Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Andras Bibok, Rahul Mhaskar, Rohit Jain, Jingsong Zhang, Jessica Frakes, Mayer N Fishman

Cardiovasc Intervent Radiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma.
Thomas E Hutson, M Dror Michaelson, Timothy M Kuzel, Neeraj Agarwal, Ana M Molina, Mayer N Fishman

Eur Urol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, Ulka Vaishampayan, Sumanta K Pal, Mayer N Fishman

Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
Aasha I Hoogland, Heather S L Jim, Brian D Gonzalez, Brent J Small, Danielle Gilvary, Mayer Fishman

Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial.
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, Mayer N Fishman, David F McDermott

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma.
Jean-François Martini, Elizabeth R Plimack, Toni K Choueiri, David F McDermott, Igor Puzanov, Mayer N Fishman

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: 2-year follow up of pembrolizumab as second-line therapy for advanced urothelial cancer ("KEYNOTE 045").
Mayer Fishman

Transl Androl Urol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Martin H Voss, Rupal S Bhatt, Nicholas J Vogelzang, Mayer Fishman, Robert S Alter

Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
Elizabeth I Buchbinder, Janice P Dutcher, Gregory A Daniels, Brendan D Curti, Sapna P Patel, Mayer N Fishman

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer.
Charles C Peyton, Dominic Tang, Richard R Reich, Mounsif Azizi, Juan Chipollini, Mayer Fishman

JAMA Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience.
Charles C Peyton, Mounsif Azizi, Juan Chipollini, Cesar Ercole, Mayer Fishman

Clin Genitourin Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
Juan Marcos González, Justin Doan, David J Gebben, Marco Boeri, Mayer Fishman

Pharmacoeconomics· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer.
Michael Poch, MacLean Hall, Autumn Joerger, Krithika Kodumudi, Matthew Beatty, Mayer N Fishman

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, Mayer N Fishman, David F McDermott

Lancet Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
Brian D Gonzalez, Brent J Small, Mallory G Cases, Noelle L Williams, Mayer N Fishman

Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Kristine A Donovan, Brian D Gonzalez, Ashley M Nelson, Mayer N Fishman, Babu Zachariah

Psychooncology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Tanya B Dorff, Jeff A Longmate, Sumanta K Pal, Walter M Stadler, Mayer N Fishman

Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive.
Mayer N Fishman

Transl Androl Urol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.
Thomas Powles, Peter H O'Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W Friedlander, Mayer N Fishman

JAMA Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma.
Brian I Rini, Victor Gruenwald, Eric Jonasch, Mayer N Fishman, Yoshihiko Tomita

Target Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P Bro, Mayer Fishman

J Natl Compr Canc Netw· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic and Provider Based Disparities in the Management of Stage I Testicular Cancer.
Gautum Agarwal, Pranav Sharma, Oscar Valderrama, Hui-Yi Lin, Binglin Yue, Mayer Fishman

Urol Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis